Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults aged between 18-60 years with Type 2 Diabetes Mellitus CURRENTLY on antidiabetic medication: a. With HbA1c currently within normal limits. b. Willing for OPD follow-up at predefined frequency. c. Able to speak and read either English or Hindi or both. d. Owns and operates or has accompanying attendant(s) willing to give access to a smartphone or device for telehealth consultations at predefined frequency. e. Willing and able to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients requiring insulin therapy or emergency management during three months starting from enrolment day. 2. Patients with learning difficulties, vision and/or hearing impairments, or any disease that impairs ability to complete the study or follow-up protocol. 3. Pregnant female or females planning to conceive
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measure changes in Medication adherence within each group using MMAS-8 scale and comparing the scores between groupsTimepoint: At 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of the Morisky Medication Adherence Scale (MMAS-8) scores in each arm with its respective pill-count method scores at the end of 3 monthsTimepoint: At 3 months;Change in HbA1c and fasting blood glucose levels in each study arm, and its correlation with changes in adherence to antidiabetic medicationsTimepoint: At 3 months;Cost effectiveness of both approaches will be compared using Incremental Cost Effectiveness Ratio (ICER) formulaTimepoint: At 3 months | — |
Countries
India
Contacts
AIIMS RISHIKESH